# Burosumab and 1-25 (OH) Vitamin D on Human Osteoclasts

> **NCT04184661** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 52 (actual)

## Conditions studied

- Hypophosphatemic Rickets

## Interventions

- **OTHER:** blood sample

## Key facts

- **NCT ID:** NCT04184661
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-20
- **Primary completion:** 2021-10-27
- **Final completion:** 2021-10-27
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2022-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04184661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04184661, "Burosumab and 1-25 (OH) Vitamin D on Human Osteoclasts". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04184661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*